Literature DB >> 24144988

Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population.

Guojiang Jin1, Hui Kang2, Xin Chen3, Di Dai3.   

Abstract

Hepatitis C virus (HCV) infection is associated with both viral and host factors. Cytokines, such as interferon (IFN)-λ, play a critical role in modulating the innate and adaptive immune systems. This study aims to investigate the association between single-nucleotide polymorphisms (SNPs) of interleukin (IL) 28B, IL10RB, and IL28RA genes and susceptibility to HCV infection in a population from the Liaoning Province of China. We used high resolution melt-polymerase chain reaction (HRM-PCR) analyses for genotype 6 polymorphisms in these genes in 271 chronic HCV-infected patients and in 300 healthy control subjects. The distribution of IL10RB and IL28RA genotypes among the HCV-infected and control groups did not differ significantly. However, we did find that the four IL28B variants were in complete linkage disequilibrium (r(2) = 0.831-0.922), and the frequency of rs8099917 GT genotype was significantly higher among chronic HCV-infected patients than among controls (OR = 2.21, 95% CI = 1.33-3.68, P = 0.00193); the G allele was found more frequently in the chronic HCV-infected group than in the control group (OR = 2.10, 95% CI = 1.28-3.44, P = 0.00276). Haplotype analysis showed that IL28B (rs12980275, rs11881222, rs12979860 and rs8099917) haplotype AACT had a protective effect for HCV infection (OR = 0.52, 95% CI = 0.33-0.83, P = 0.00551). This study indicates that the four SNPs in IL28B are correlated with susceptibility to HCV infection.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatitis C virus (HCV); High resolution melt (HRM); IL10RB; IL28B; IL28RA; Polymorphism

Mesh:

Substances:

Year:  2013        PMID: 24144988     DOI: 10.1016/j.meegid.2013.10.009

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

1.  Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.

Authors:  Zainab A Zakaria; Susanne Knapp; Mohamed Hashem; Hassan Zaghla; Mark Thursz; Imam Waked; Sayed Abdelwahab
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

2.  The vitamin D receptor gene ApaI polymorphism is associated with increased risk of renal cell carcinoma in Chinese population.

Authors:  Chunming Yang; Jia Li; Yan Li; Di Wu; Chengguang Sui; Youhong Jiang; Fandong Meng
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 3.  Interferon Lambda: Modulating Immunity in Infectious Diseases.

Authors:  Mohammedyaseen Syedbasha; Adrian Egli
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

4.  Polymorphisms in the Th17 cell-related RORC gene are associated with spontaneous clearance of HCV in Chinese women.

Authors:  Zhe Xie; Yuantao Li; Lu Long; Hua Liang; Weiping Cai; Tao Shen
Journal:  BMC Infect Dis       Date:  2018-06-04       Impact factor: 3.090

Review 5.  The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases.

Authors:  Samantha J Griffiths; Cory M Dunnigan; Clark D Russell; Jürgen G Haas
Journal:  J Innate Immun       Date:  2015-01-23       Impact factor: 7.349

6.  Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children.

Authors:  Rong-Rong Wu; Feng-Qun Liu; Shi-Shu Zhu; Jin Han
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

7.  Novel susceptibility loci for A(H7N9) infection identified by next generation sequencing and functional analysis.

Authors:  Baihui Zhao; Yongkun Chen; Mo Li; Jianfang Zhou; Zheng Teng; Jian Chen; Xue Zhao; Hao Wu; Tian Bai; Shenghua Mao; Fanghao Fang; Wei Chu; Hailiang Huang; Cong Huai; Lu Shen; Wei Zhou; Liangdan Sun; Xiaodong Zheng; Guangxia Cheng; Ye Sun; Dayan Wang; Lin He; Yuelong Shu; Xi Zhang; Shengying Qin
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.